Phase Ib trial of ALT-803, an IL-15 superagonist, plus BCG for the treatment of BCG-naive patients with non-muscle-invasive bladder cancer.

被引：11
|
作者：
Rosser, Charles Joel
Nix, Jeffrey
Ferguson, Lydia
Hernandez, Liza
Wong, Hing C.
机构：
[1] Univ Hawaii Canc Ctr, Honolulu, HI USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Altor BioScience, Miramar, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
510
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer
    D'Andrea, David
    Soria, Francesco
    Abufaraj, Mohammad
    Pones, Mario
    Gontero, Paolo
    Machado, Andre T.
    Waksman, Ricardo
    Enikeev, Dmitry V.
    Glybochko, Petr V.
    Adonias, Sanarelly Pires
    Nahas, William Carlos
    Shariat, Shahrokh F.
    Chade, Daher C.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (01) : 20 - +
  • [32] N-803 Plus BCG Treatment for BCG-Naïve or -Unresponsive Non-Muscle Invasive Bladder Cancer: A Plain Language Review
    Chamie, Karim
    Chang, Sam S.
    Rosser, Charles J.
    Kramolowski, Eugene
    Gonzalgo, Mark L.
    Sexton, Wade J.
    Spilman, Patricia
    Sender, Lennie
    Reddy, Sandeep
    Soon-Shiong, Patrick
    FUTURE ONCOLOGY, 2024, 20 (31) : 2307 - 2317
  • [33] A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Gu ′erin (BCG) for patients with BCG-exposed, high-grade, non-muscle-invasive bladder cancer.
    Gaffney, Christopher
    DSouza, Neeta
    Hernandez, Christian
    McCarter, Melissa
    Moran, Patricia
    Stasi, Kristen
    Worth, Kara
    Dalbagni, Guido
    Donahue, Timothy F.
    Donat, S. Machele
    Bochner, Bernard H.
    Sarungbam, Judy
    Bajorin, Dean F.
    Al-Ahmadie, Hikmat A.
    Sjoberg, Daniel D.
    Goh, Alvin C.
    Pietzak, Eugene J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [34] Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
    Jaromin, Maciej
    Konecki, Tomasz
    Kutwin, Piotr
    CANCERS, 2024, 16 (07)
  • [35] Adjuvant cancer peptide vaccine treatment with intravesical BCG therapy for non-muscle-invasive bladder cancer
    Obara, Wataru
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] BCG plus Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned
    Hayne, Dickon
    Stockler, Martin
    McCombie, Steve P.
    Lawrence, Nicola
    Martin, Andrew
    Sengupta, Shomik
    Davis, Ian D.
    BJU INTERNATIONAL, 2017, 119 : 55 - 57
  • [37] Final clinical results of pivotal trial of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive CIS and papillary nonmuscle-invasive bladder cancer (NMIBC).
    Chamie, Karim
    Chang, Sam S.
    Gonzalgo, Mark
    Kramolowsky, Eugene V.
    Sexton, Wade J.
    Bhar, Paul
    Reddy, Sandeep K.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] BCG plus MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
    Hayne, Dickon
    Stockler, Martin
    McCombie, Steve P.
    Chalasani, Venu
    Long, Anne
    Martin, Andrew
    Sengupta, Shomik
    Davis, Ian D.
    BMC CANCER, 2015, 15
  • [39] Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
    Li, Roger
    Shah, Paras H.
    Stewart, Tyler F.
    Nam, Jong Kil
    Bivalacqua, Trinity J.
    Lamm, Donald L.
    Uchio, Edward M.
    Geynisman, Daniel M.
    Jacob, Joseph M.
    Meeks, Joshua J.
    Dickstein, Rian
    Pearce, Shane M.
    Kang, Seok Ho
    Jung, Seung Il
    Kamat, Ashish M.
    Burke, James M.
    Keegan, Kirk A.
    Steinberg, Gary D.
    NATURE MEDICINE, 2024, 30 (06)
  • [40] Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder cancer. Considerations in Latin America
    Fernandez, M. I.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (04): : 257 - 259
12345